Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Cash from Investing Activities (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Cash from Investing Activities for 3 consecutive years, with $87.1 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 68.2% to $87.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $99.5 million through Dec 2025, down 18.89% year-over-year, with the annual reading at $99.5 million for FY2025, 18.89% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was $87.1 million at Nuvation Bio, up from -$96.6 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $87.1 million in Q4 2025, with the low at -$96.6 million in Q3 2025.
  • Average Cash from Investing Activities over 3 years is $19.3 million, with a median of $33.7 million recorded in 2023.
  • Peak annual rise in Cash from Investing Activities hit 618.4% in 2025, while the deepest fall reached 431.85% in 2025.
  • Over 3 years, Cash from Investing Activities stood at $33.2 million in 2023, then surged by 56.11% to $51.8 million in 2024, then skyrocketed by 68.2% to $87.1 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $87.1 million, -$96.6 million, and $54.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.